Biotech

All Articles

AstraZeneca blog posts records on in-house rivals to AbbVie, Pfizer ADCs

.AstraZeneca has actually discussed a very early examine the efficiency of its own internal antibody...

iTeos- GSK's TIGIT star presents relevant renovation

.After revealing a period 3 launch based on positive midstage results, iTeos and also GSK are ultima...

More collaborative FDA may increase uncommon condition R&ampD: report

.The FDA must be actually even more available as well as collective to unleash a surge in approvals ...

Zenas, MBX, Bicara scalp to Nasdaq in scorching day for biotech IPOs

.It is actually an unusually busy Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bica...

Atea's COVID antiviral neglects to stop hospitalizations in stage 3

.Atea Pharmaceuticals' antiviral has actually neglected one more COVID-19 trial, but the biotech sti...

Neurocrine's offer to save mental illness possibility fails

.Neurocrine Biosciences' schizophrenia course pivot has actually neglected. The biotech was actually...

Sanofi pays out $110M upfront for late-stage radioligand therapy

.Sanofi has created a late access to the radioligand gathering, paying for 100 thousand euros ($ 110...

F 2G raises $100M for 2nd effort to get new antifungal to market

.After F2G's 1st effort to acquire a new course of antifungal to market was actually hindered by the...

Moderna targets $1.1 B in R&ampD spending slices, drops 5 programs among profits tensions

.Moderna has promised to cut R&ampD investing through $1.1 billion by 2027. The choice to shrink the...

Sanofi's $80M bank on Key dystrophy medicine finishes in period 3 lose big

.Merely 4 months after Sanofi wager $80 thousand in ahead of time money on Fulcrum Rehabs' losmapimo...